Impact of Xuesaitong United Batroxobin on Serum hsCRP and Plasma vWF in Patients with Acute Cerebral Infarction
|更新时间:2024-01-04
|
Impact of Xuesaitong United Batroxobin on Serum hsCRP and Plasma vWF in Patients with Acute Cerebral Infarction
Chinese Journal of Experimental Traditional Medical FormulaeVol. 17, Issue 11, Pages: 251-253(2011)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2011
稿件说明:
移动端阅览
ZHANG Wei, WANG Yuan-bo, LIU Yang, et al. Impact of Xuesaitong United Batroxobin on Serum hsCRP and Plasma vWF in Patients with Acute Cerebral Infarction[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(11): 251-253.
DOI:
ZHANG Wei, WANG Yuan-bo, LIU Yang, et al. Impact of Xuesaitong United Batroxobin on Serum hsCRP and Plasma vWF in Patients with Acute Cerebral Infarction[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(11): 251-253.DOI:
Impact of Xuesaitong United Batroxobin on Serum hsCRP and Plasma vWF in Patients with Acute Cerebral Infarction
Objective: To explore the impact of Xuesaitong United Batroxobin on serum hsCRP and plasma vWF levels in patients with acute cerebral infarction. Method: Eighty-two patients with acute cerebral infarction were divided into control group (n=41) and treatment group (n=41).Control group patients were treated with Xuesaitong iv injection 20 mL with 250 mL saline once daity for (d 1-d 4).Based on the application of the control group
the treatment group patients were additionally treated with Batroxobin 20 mL in 250 mL normal saline intravenously for d 1
d 3
d 5. The neurological deficit score and plasma vWF levels
serum hsCRP level were observed in this two groups
before treatment and after treatment 7
14 d. Result: The neurological deficit scores were significantly lower in the treatment group and control group
after 7
14 d (P<0.01).Compared with the control group
treatment group decreased more significantly (P<0.01).Compared with that before treatment
plasma vWF and serum hsCRP levels were significantly increased after 7 d (P<0.01)
compared with the control group
treatment group increased more significantly (P<0.01);14 d plasma vWF levels and serum hsCRP levels were significantly lower (P<0.01)
the treatment group decreased more significantly (P<0.01). Conclusion: Xuesaitong United Batroxobin appears to be better than the treatment of acute cerebral infarction by Xuesaitong alone.
Effect of Tongnaoyin on Cerebral Hemodynamics in Patients with Acute Cerebral Infarction of Phlegm and Blood Stasis Syndrome Based on CTA/CTP
Comparison on Rat Models of Acute Cerebral Infarction Due to Stasis Combined with Toxin Complicated with Cerebral-cardiac Syndrome
Clinical Effect of Erchentang and Bixie Fenqingyin Combined on Patients with Acute Cerebral Infarction with Hyperuricemia with Syndrome of Phlegm and Blood Stasis Blocking Collaterals
Effect of Activating Blood Therapy of Traditional Chinese Medicine on Inflammatory Factors in Patients with Acute Cerebral Infarction: A Review
Related Author
JI Lianhong
LIU Peian
LI Li
LI Yunze
ZHU Qing
TANG Xiaogang
JIANG Hui
LIU Yongkang
Related Institution
The Affiliated Hospital of Nanjing University of Chinese Medicine/ Jiangsu Province Hospital of Chinese Medicine
Beijing Key Laboratory of Pharmacology of Chinese Materia Medica,Institute of Basic Medical Sciences,Xiyuan Hospital,China Academy of Chinese Medical Sciences
Xiyuan Hospital, China Academy of Chinese Medical Sciences
Putuo Hospital,Shanghai University of Tranditional Chinese Medicine(TCM)
Shuguang Hospital Affiliated to Shanghai University of TCM